MRX-6 Cream Did Not Demonstrate Separation from Vehicle in Primary Endpoint of Percent Improvement in the Investigator's Global Assessment NEW YORK and …

[Read more...] about Celsus Therapeutics Announces That the Phase II Trial of MRX-6 Cream 2% in Pediatric Atopic Dermatitis Did Not Reach Primary Endpoint

NEW YORK and LONDON, January 13, 2015 Topline data from double-blind portion of trial expected by end of February, 2015 Celsus Therapeutics (NASDAQ: …

[Read more...] about Celsus Therapeutics Completes Enrollment of Phase II Trial of MRX-6 Cream 2% in Pediatric Atopic Dermatitis

NEW YORK and LONDON, January 12, 2015 Phase II dose ranging clinical trial in atopic dermatitis expected to begin in first quarter of 2015 Celsus …

[Read more...] about Celsus Therapeutics Announces FDA Allowance of IND for Clinical Development of MRX-6 Cream in Atopic Dermatitis